Classical Shastrayoga formulations are faster to licence and launch; proprietary medicines offer formulation freedom but require additional regulatory groundwork.
Classical Shastrayoga formulations from authoritative Ayurvedic texts can be licensed and launched faster because their formula, dose, and indications are already documented and accepted by regulators. Proprietary Ayurvedic medicines give you formulation freedom but require additional regulatory steps. Understanding the difference is essential before you brief a manufacturer or file for a licence.
Shastrayoga means a formulation described in a classical Ayurvedic text (shastra). The reference texts accepted by Indian regulators include the Bhaishajya Ratnavali, Sharangdhar Samhita, Ashtanga Hridayam, Charaka Samhita, Sushruta Samhita, and the Ayurvedic Formulary of India (AFI), which is a government-compiled compendium. Every ingredient, its proportion, the method of preparation, and the intended therapeutic indication are specified in these texts.
Because the formula is pre-documented, a state licencing authority can verify it against the published reference without requiring new clinical data. This is the primary regulatory advantage of classical formulations: the groundwork has already been established across centuries of codified practice and is recognised in Indian law.
Raasa Ayurveda's manufacturing focus is entirely on classical Shastrayoga products. The 339 formulations in its catalogue span every major classical category, from Ras Rasayana and Bhasma-Pishti to Asava-Arishta and Avaleha.
A proprietary Ayurvedic medicine (PAM) is a branded product with a formula that is not listed verbatim in any approved classical text. The manufacturer or brand owner develops or adapts the formulation, typically by combining classical ingredients in non-classical ratios or by adding ingredients outside any single reference preparation.
PAMs must use ingredients listed in the schedules of the Drugs and Cosmetics Act, 1940, and cannot make claims not supported by classical texts or established Ayurvedic literature. They are manufactured under the same Schedule T GMP framework as classical products, but the licencing authority evaluates the formula independently rather than cross-referencing a textual source.
A significant share of the modern Ayurvedic consumer market is PAM-based, from combination immunity supplements to sugar-free adaptogen blends designed for contemporary lifestyles.
Both classical and proprietary Ayurvedic medicines are governed by the Drugs and Cosmetics Act, 1940, and the Rules thereunder, with Schedule T setting GMP standards for Ayurvedic, Siddha, and Unani drugs. The AYUSH Ministry oversees national policy, and state licencing authorities issue manufacture and sale licences. The divergence lies in how each type of formulation is evaluated.
| Criterion | Shastrayoga (Classical) | Proprietary Ayurvedic Medicine |
|---|---|---|
| Formula source | Documented in approved classical text or AFI | Developed by brand owner or manufacturer |
| Licencing speed | Generally faster, formula pre-accepted | Requires independent formula review |
| Indication claims | Drawn directly from classical text | Must align with available Ayurvedic literature |
| Regulatory risk | Lower for well-established preparations | Higher, especially for novel ingredient claims |
| Market precedent | Widely manufactured and dispensed | Varies by formulation novelty |
| Classical expertise required | High, at manufacturer level | Moderate to high |
The practical implication for a brand owner launching quickly: a classical product can move from brief to batch record faster because your contract manufacturer already has the formulation, the formula is fixed in a published text, and the licencing authority has a clear reference to check. For a detailed look at the full licencing process, see our post on Ayurvedic manufacturing licences in India.
Classical formulations carry inherent credibility in practitioner channels. A vaidya (classical Ayurvedic practitioner) will prescribe Kanchanar Guggulu or Dashamularishta by name because those names carry clinical meaning rooted in the texts. Your brand becomes the vehicle for a well-understood preparation, and your differentiation comes from quality, packaging, and service rather than the formula itself.
Proprietary medicines suit direct-to-consumer brands targeting modern lifestyle categories such as stress management, sleep support, metabolic health, and skin wellness. These products can be positioned around a proprietary blend, a unique delivery format, or a flavour profile that classical formulations do not offer. The trade-off is that building consumer trust around an unfamiliar formula requires more marketing investment and a longer sales cycle.
A hybrid approach is common among growing brands: launch on classical formulations for immediate credibility and cash flow, then develop one or two proprietary products as a differentiator once distribution is in place. If you are starting from scratch, our post on how to start your own Ayurvedic brand covers the full sequence from formulation choice to market entry.
For a classical product, your manufacturer needs:
For a proprietary product, you will additionally need to provide:
A manufacturer operating under a valid GMP framework will advise on whether your proprietary formula falls within permissible ingredient lists and what supporting documentation is required for the state authority's review.
For most brand owners working with a contract manufacturing partner for the first time, classical formulations offer the lowest barrier to a compliant launch. You are not developing a new formula, your manufacturer already holds batch records for the product, and your licence application cites a published classical text. The variables you control are quality, branding, and route to market.
Proprietary formulations make commercial sense when you have a specific market gap to address, a differentiated ingredient story, or a consumer segment that classical product names will not reach. In that case, plan for a longer pre-launch phase and ensure your manufacturer has the expertise to help document the formula for regulatory submission.
For buyers exploring classical dosage forms in detail before making a sourcing decision, the companion post on Ayurvedic dosage forms explained covers shelf life, packaging implications, and buyer profiles for each major form.
Raasa Ayurveda's 339-product classical range spans Guggulu, Vati, Bhasma-Pishti, Taila, and ten other categories, all manufactured in Kanpur under an established GMP framework. To discuss whether a classical or proprietary route is right for your next product, call the team at +91 9415128217 or write to raasaayurveda@gmail.com.
A classical Ayurvedic medicine follows a formula documented in an approved textual source such as the Bhaishajya Ratnavali or the Ayurvedic Formulary of India. A proprietary Ayurvedic medicine uses a formula created by the brand or manufacturer that does not appear verbatim in any classical reference. Both are manufactured under Schedule T GMP but take different regulatory paths to licencing.
Generally, yes. Proprietary formulations require the licencing authority to evaluate the formula independently, whereas classical formulations can be checked against a published text. This typically adds documentation requirements and review time to the pre-launch phase. The degree of difficulty varies with the novelty of the ingredients and the indication claims intended.
Yes. Classical formulations can be manufactured to your specification and sold under your brand name, provided labelling meets requirements under the Drugs and Cosmetics Act. The formula remains as defined in the classical reference, but your brand identity, packaging, and positioning are entirely your own. Many successful Ayurvedic brands are built entirely on classical formulations.
For Shastrayoga formulations listed in approved classical texts, clinical trial data is not required for licencing. The classical texts themselves are accepted as the basis for recognised therapeutic use and safety in the Indian regulatory framework. Proprietary formulations may require additional supporting literature depending on the indications claimed and the ingredients involved.
Raasa Ayurveda, 49/72-A, Naughara, Kanpur 208001, Uttar Pradesh, India. Telephone +91 9415128217. Email raasaayurveda@gmail.com.